Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADX-629 in chronic cough
NCT05392192Phase 2Completed
- Sponsor
- Aldeyra Therapeutics
- Start
- Apr 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acloproxalap in chronic cough, sponsored by Aldeyra Therapeutics. Started Apr 2022; status: completed.
02
Drugs
acloproxalap
03
Conditions
chronic cough
Beyond the preview
Go deeper on NCT05392192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05392192.